Risk for Reoperation After First MTP Joint Arthrodesis
1 other identifier
observational
1,213
1 country
1
Brief Summary
We will screen all first metatarsophalangeal joint arthrodeses performed between 2010 and 2022 in Helsinki University Hospital. Information about demographics and additional diagnoses will be yielded from data pool of medical records. Additionally we review pre- and post-operative x-rays for first MTP joint angles and OR records for operative techniques. Our aim is to find associations between those known variables and risk for reoperation in two years after operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 21, 2023
CompletedFirst Posted
Study publicly available on registry
April 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
February 29, 2024
February 1, 2024
4.3 years
March 21, 2023
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of reoperations
Any OR located reoperation
2 years
Study Arms (2)
Reoperated
Primary arthrodesis operations later requiring reoperation.
Control
Primary arthrodesis operations with no further operations. Size of the control group is four fold.
Interventions
Surgery leadin to bony uninon in firts metatarsophalangeal joint
Eligibility Criteria
All patients treated in Helsinki University Hospital in 2010-2022
You may qualify if:
- First MTPJ arthrodesis
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helsinki University Hospital
Helsinki, 00029 HUS, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Principal Investigator
Study Record Dates
First Submitted
March 21, 2023
First Posted
April 3, 2023
Study Start
October 1, 2022
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
February 29, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share